Replies to post #371999 on Innovation Pharmaceuticals Inc (IPIX)

[Brinjal]

Brilacidin's mechanism is three pronged unlike Remdesivir.

As Farrell and KMBJN succintly discussed at length here recently, the mechanism by which Brilacidin disrupts the viral membrane is unique and is extra-cellular, whereas Remdesivir is intra-cellular which itself presents a problem. Moreover, Brilacidin is anti-inflammatory and anti-bacterial, something that Remdesivir lacks.

A high SI of Remdesivir did enable it to succeed in-vivo and receive an EUA (though the extent of its success is under debate). Isn't there a higher probability for Brilacidin to succeed?

Note: I am not in the bio-medical field, so I used layman's terms to express my understanding. But the gentlemen I referred to above have explained it beautifully elsewhere.

[attilathehunt]

"previous studies then over 50% of subjects will experience adverse events, some of them serious. "


What could be worse than dying?


Whaaa-whaaa-whaaa

[williamssc]

1000 SI Not according to Cell Research which compared the following-

Remdesivir SI 129.87
Cloroquine SI 88.5
Favipiravir SI 6.46
Penciclovir SI 4.17
Ribavirin SI 3.65

https://www.nature.com/articles/s41422-020-0282-0

We now know Brilacidin 426 SI

Thanks to those who had posted this earlier.